HomeCompareNUGX vs HDV

NUGX vs HDV: Dividend Comparison 2026

NUGX yields 2000000.00% · HDV yields 2.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NUGX wins by $4.879226400974806e+39M in total portfolio value
10 years
NUGX
NUGX
● Live price
2000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.879226400974806e+39M
Annual income
$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00
Full NUGX calculator →
HDV
iShares Core High Dividend ETF
● Live price
2.92%
Share price
$135.39
Annual div
$3.96
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.3K
Annual income
$352.73
Full HDV calculator →

Portfolio growth — NUGX vs HDV

📍 NUGX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNUGXHDV
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NUGX + HDV cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NUGX pays
HDV pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NUGX
Annual income on $10K today (after 15% tax)
$170,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/yr
HDV
Annual income on $10K today (after 15% tax)
$248.52/yr
After 10yr DRIP, annual income (after tax)
$299.82/yr
At 15% tax rate, NUGX beats the other by $4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NUGX + HDV for your $10,000?

NUGX: 50%HDV: 50%
100% HDV50/50100% NUGX
Portfolio after 10yr
$2.439613200487403e+39M
Annual income
$2,439,373,269,665,485,000,000,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.99%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NUGX buys
0
HDV buys
0
No recent congressional trades found for NUGX or HDV in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNUGXHDV
Forward yield2000000.00%2.92%
Annual dividend / share$2.00$3.96
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$4.879226400974806e+39M$24.3K
Annual income after 10y$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00$352.73
Total dividends collected$4.879195005460081e+39M$3.2K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: NUGX vs HDV ($10,000, DRIP)

YearNUGX PortfolioNUGX Income/yrHDV PortfolioHDV Income/yrGap
1← crossover$200,010,700$200,000,000.00$11,002$292.38+$200.00MNUGX
2$3,738,731,768,458$3,738,517,757,009.35$12,084$300.36+$3738731.76MNUGX
3$65,315,062,866,930,490$65,311,062,423,938,240.00$13,250$308.02+$65315062866.92MNUGX
4$1,066,400,830,062,625,000,000$1,066,330,942,945,357,500,000.00$14,506$315.35+$1066400830062625.00MNUGX
5$16,272,182,796,453,826,000,000,000$16,271,041,747,565,660,000,000,000.00$15,858$322.35+$16272182796453826560.00MNUGX
6$232,054,240,113,661,900,000,000,000,000$232,036,828,878,069,680,000,000,000,000.00$17,313$329.04+$2.3205424011366188e+23MNUGX
7$3,092,799,066,104,688,500,000,000,000,000,000$3,092,550,768,067,767,400,000,000,000,000,000.00$18,878$335.42+$3.0927990661046884e+27MNUGX
8$38,524,105,697,352,694,000,000,000,000,000,000,000$38,520,796,402,351,967,000,000,000,000,000,000,000.00$20,560$341.49+$3.8524105697352695e+31MNUGX
9$448,468,826,014,798,700,000,000,000,000,000,000,000,000$448,427,605,221,702,600,000,000,000,000,000,000,000,000.00$22,367$347.25+$4.484688260147987e+35MNUGX
10$4,879,226,400,974,806,000,000,000,000,000,000,000,000,000,000$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00$24,307$352.73+$4.879226400974806e+39MNUGX

NUGX vs HDV: Complete Analysis 2026

NUGXStock

NuGenerex Immuno-Oncology, Inc., an oncology company, focuses on the modulation of the immune system to treat cancer. The company is developing immunotherapeutic products and vaccines. It is developing AE37, a peptide immunotherapeutic vaccine, which is in Phase II clinical trials for the treatment of metastatic triple negative breast cancer. The company was formerly known as Antigen Express, Inc. The company was founded in 1993 and is based in Miramar, Florida. NuGenerex Immuno-Oncology, Inc.is a subsidiary of Generex Biotechnology Corporation.

Full NUGX Calculator →

HDVETF

The iShares Core High Dividend ETF seeks to track the investment results of an index composed of relatively high dividend paying U.S. equities.

Full HDV Calculator →
📬

Get this NUGX vs HDV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NUGX vs SCHDNUGX vs JEPINUGX vs ONUGX vs KONUGX vs MAINNUGX vs VYMNUGX vs DVYNUGX vs SPHD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.